HSCEI Index Rebalances - The Year of the Ox and of More Change
There will be a lot of changes to the HSCEI this year that will impact the sectoral composition and open up trading opportunities on the stocks and...
785 Views
Kuaishou IPO: Is It Worth Twice the IPO Price?
Kuaishou's grey market price has hit HK$250 per share, slightly more than 2x the IPO price of HK$115. Our analysis suggests that this valuation can...
552 Views
ECM Weekly (31 January 2021) - Kuaishou, Basecare Med, MicroPort Cardioflow, Cloopen
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
638 Views
Tencent: An Update on Investees and the Implied Valuation of Consolidated Operations
In this insight, I account for the increase in fair value of Tencentās investees, including the Kuaishou IPO, which indicates that consolidated...
410 Views
Suzhou Basecare Medical IPO Valuation: Attractive Even at the Upper End of the IPO Pricing
Suzhou Basecare offers an innovative platform of genetic testing solutions for assisted reproduction in China In this insight, we examine the...
468 Views